These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 15699069

  • 1. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H, Inoue A, Toyama-Sorimachi N, Nagai Y, Yasuda T, Suzuki H, Horai R, Iwakura Y, Yamamoto T, Karasuyama H, Miyake K, Yamanashi Y.
    J Exp Med; 2005 Feb 07; 201(3):333-9. PubMed ID: 15699069
    [Abstract] [Full Text] [Related]

  • 2. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T, Barton GM, Flavell RA, Medzhitov R.
    Nature; 2002 Nov 21; 420(6913):329-33. PubMed ID: 12447442
    [Abstract] [Full Text] [Related]

  • 3. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN.
    Nat Immunol; 2002 Apr 21; 3(4):392-8. PubMed ID: 11896392
    [Abstract] [Full Text] [Related]

  • 4. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T, Bundo K, Hino A, Honda K, Inoue A, Shirakata M, Osawa M, Tamura T, Nariuchi H, Oda H, Yamamoto T, Yamanashi Y.
    Int Immunol; 2007 Apr 21; 19(4):487-95. PubMed ID: 17329234
    [Abstract] [Full Text] [Related]

  • 5. Different Toll-like receptor agonists induce distinct macrophage responses.
    Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, Fenton MJ.
    J Leukoc Biol; 2001 Jun 21; 69(6):1036-44. PubMed ID: 11404392
    [Abstract] [Full Text] [Related]

  • 6. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
    Martin L, Pingle SC, Hallam DM, Rybak LP, Ramkumar V.
    J Pharmacol Exp Ther; 2006 Jan 21; 316(1):71-8. PubMed ID: 16188954
    [Abstract] [Full Text] [Related]

  • 7. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ, Johnston DG, Lynch MA.
    Mol Cell Neurosci; 2013 Sep 21; 56():148-58. PubMed ID: 23659921
    [Abstract] [Full Text] [Related]

  • 8. Dok-1 tyrosine residues at 336 and 340 are essential for the negative regulation of Ras-Erk signalling, but dispensable for rasGAP-binding.
    Shinohara H, Yasuda T, Yamanashi Y.
    Genes Cells; 2004 Jun 21; 9(6):601-7. PubMed ID: 15189452
    [Abstract] [Full Text] [Related]

  • 9. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages.
    Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C.
    Mol Immunol; 2008 Apr 21; 45(7):2007-16. PubMed ID: 18061674
    [Abstract] [Full Text] [Related]

  • 10. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
    Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, Hirai H, Oda H, Yamamoto T, Yamanashi Y.
    J Exp Med; 2004 Dec 20; 200(12):1681-7. PubMed ID: 15611294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
    Clarke JH, Cha JY, Walsh MD, Gamboni-Robertson F, Banerjee A, Reznikov LL, Dinarello CA, Harken AH, McCarter MD.
    J Am Coll Surg; 2005 Sep 20; 201(3):418-25. PubMed ID: 16125076
    [Abstract] [Full Text] [Related]

  • 13. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J.
    Hepatology; 2005 Mar 20; 41(3):443-50. PubMed ID: 15723296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4.
    Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, Sohn KH, Jang B, Ye J, Chung JH, Hwang DH.
    Biochem Pharmacol; 2005 Oct 15; 70(8):1231-40. PubMed ID: 16140274
    [Abstract] [Full Text] [Related]

  • 16. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.
    Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S.
    J Am Soc Nephrol; 2004 May 15; 15(5):1289-99. PubMed ID: 15100369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
    Lin MW, Tsao LT, Chang LC, Chen YL, Huang LJ, Kuo SC, Tzeng CC, Lee MR, Wang JP.
    Biochem Pharmacol; 2007 Jun 01; 73(11):1796-806. PubMed ID: 17379190
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, Li YC, Geng JG, Zuo JP.
    J Pharmacol Exp Ther; 2006 Jan 01; 316(1):121-8. PubMed ID: 16166270
    [Abstract] [Full Text] [Related]

  • 20. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
    Wu GJ, Chen TL, Ueng YF, Chen RM.
    Toxicol Appl Pharmacol; 2008 Apr 01; 228(1):105-13. PubMed ID: 18191973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.